GE HealthCare Techs Raises FY2025 Adj EPS Guidance From $3.90-$4.10 to $4.43-$4.63 vs $4.07 Est

Author: Benzinga Newsdesk | July 30, 2025 05:22am

2025 guidance

Today, the Company raises 2025 full-year guidance, reflective of healthy capital investment trends, operational execution and changes in tariff rates, as follows:

• Organic revenue growth* of approximately 3% year-over-year; this compares to previous Organic revenue growth* guidance of 2% to 3%
• Adjusted EBIT margin* of 15.2% to 15.4%, reflecting a decline of 110 bps to 90 bps versus 2024 Adjusted EBIT margin* of 16.3%; this compares to previous Adjusted EBIT margin* guidance of 14.2% to 14.4%
• Adjusted effective tax rate (ETR)* in the range of 20% to 21%; this compares to previous Adjusted ETR* guidance of 21% to 22%
• Adjusted EPS* in the range of $4.43 to $4.63, which includes approximately $0.45 of tariff impact versus 2024 Adjusted EPS* of $4.49; this compares to previous Adjusted EPS* guidance in the range of $3.90 to $4.10
• Free cash flow* of at least $1.4 billion; this compares to previous Free cash flow* guidance of at least $1.2 billion

Tariff assumptions for updated guidance: Bilateral U.S. and China tariffs introduced this year continue and will rise on August 12, 2025 (to a rate of 54% for U.S. tariffs imposed on goods imported from China to the U.S. and to 34% for Chinese tariffs on goods exported from the U.S. to China); U.S. reciprocal rate on EU and Japan products at 15% effective August 1, 2025; tariffs increase for goods imported from Mexico (to 30%) and from Canada (to 35%) on August 1, 2025 and USMCA exemptions for eligible imports continue; U.S. reciprocal tariffs on all other impacted geographies return to pre-pause levels on August 1, 2025, including other increases formally communicated by letter (>10%); excludes potential Section 232 tariff impact.

Posted In: GEHC